Human papillomavirus vaccine risk and reality;Le vaccin contre le virus du papillome humain: Risques et réalités

CMAJ. Canadian Medical Association Journal

Volumn 179, Issue 6, 2008, Pages 503-505

  MacDonald, Noni ^a   Stanbrook, Matthew B ^b   Hébert, Paul C ^c  

^a Section Santé Publique

^b Sciences

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; HEPATITIS B VACCINE; WART VIRUS VACCINE;

ANAPHYLACTIC SHOCK; ANAPHYLAXIS; AUSTRALIA; CANADA; CANCER IMMUNIZATION; CANCER RISK; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; EUROPE; FOLLOW UP; HEALTH PROGRAM; HEPATITIS B; HERD IMMUNITY; HUMAN; INDUSTRIALIZATION; SCHOOL HEALTH SERVICE; SEXUAL INTERCOURSE; UTERINE CERVIX CANCER; VACCINATION;

EID: 51649086085     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.081238     Document Type: Editorial

References (6)

1. Cassels AK. Vaccination against human papilloma virus [lettre]. CMAJ 2007;177:1526.
2. Brotherton JML, Gold MS, Kemp AS, et al. Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ 2008;179:525-33.
3. Halsey NA. The human papillomavirus vaccine and risk of anaphylaxis. CMAJ 2008;179:509-10.
4. Agence de la santé publique du Canada. Guide canadien d'immunisation. 7e éd. Ottawa (Ont.) : l'Agence; 2006. Disponible : www.phac-aspc.gc.ca/publicat/cig-gci/ index-fra.php (consulté le 5 août 2008).
5. Société canadienne du cancer. Statistiques canadiennes sur le cancer. Toronto (Ont.) : la Société; 2008. Disponible : www.cancer.ca/ccs/internet/standard/0,3182,3172_14279__langId-fr,00.html (consulté le 5 août 2008).
6. Dempsey AF, Gebremariam A, Koutsky L, et al. Behavior in early adolescence and risk of human papillomavirus infection as a young adult: results from a population-based study. Pediatrics 2008;122:1-7.